A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy.
Fritsch A, Loeckermann S, Kern JS, Braun A, Bösl MR, Bley TA, Schumann H, von Elverfeldt D, Paul D, Erlacher M, Berens von Rautenfeld D, Hausser I, Fässler R, Bruckner-Tuderman L.
Fritsch A, et al. Among authors: kern js.
J Clin Invest. 2008 May;118(5):1669-79. doi: 10.1172/JCI34292.
J Clin Invest. 2008.
PMID: 18382769
Free PMC article.